Malakoplakia after kidney transplantation: Case report and literature review

John Fredy Nieto-Ríos1, Isabel Ramírez2, Mónica Zuluaga-Quintero3

  • 1Nephrology, Pablo Tobón Uribe Hospital-University of Antioquia, Medellin, Colombia.

Insights

Malakoplakia, a granulomatous disease, often presents as recurrent urinary tract infections (r-UTI). Surgical management successfully treated a refractory bladder malakoplakia case in a kidney transplant recipient.

Area of Science:

  • Urology
  • Transplantation Medicine
  • Pathology

Background:

  • Malakoplakia is a rare granulomatous condition often linked to infections, primarily affecting the urinary tract.
  • It frequently manifests as recurrent urinary tract infections (r-UTI) and can lead to impaired renal function.
  • Immunosuppression, particularly in solid organ transplantation (SOT) recipients like kidney transplant patients, is a significant associated factor.

Observation:

  • Macroscopic presentation can mimic neoplasia, underscoring the diagnostic importance of histology.
  • A case of bladder malakoplakia in a renal transplant patient presented as an Escherichia coli r-UTI.
  • This case was refractory to prolonged antibiotic therapy and reduced immunosuppression.

Findings:

  • Histological examination is crucial for definitive diagnosis, differentiating malakoplakia from malignancy.
  • The presented case demonstrated treatment resistance to conventional medical management.
  • Surgical intervention led to the resolution of bladder malakoplakia in the immunosuppressed patient.

Implications:

  • This case highlights the challenges in managing malakoplakia in SOT recipients.
  • It suggests that surgical management may be a viable option for refractory cases.
  • Further research into optimal treatment strategies for malakoplakia in transplant populations is warranted.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
599
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
581
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
456
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
865
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K